Investor Contact
Media & Investor Relations:
Troy Wichterman
Chief Financial Officer
(425) 402 - 1400
twichterman@biolifesolutions.com
Transfer Agent
Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, New York 11717
USA
(877) 830 - 4936
shareholder@broadridge.com
Investor Alerts
Register here to receive email notifications with updates about our press releases, stock price, SEC filings and more.
Financials
NASDAQBLFS
Beta | 1.87 |
---|---|
Shares Outstanding | 46.1M |
Average Volume (10 days) | 256.7K |
Qtrly Dividend (Ann. Yield) | -- (--) |
Analyst Views
Current Mean Recommendation | Strong Buy |
---|
Strong Buy | 10 | |
---|---|---|
Buy | 0 | |
Hold | 0 | |
Underperform | 0 | |
Sell | 0 |
Recent Insider Transactions
Mathew Aby EVP & Chief Scientific Officer | (10,000) Sell Sep 19, 2024 |
---|---|
Mathew Aby EVP & Chief Scientific Officer | (10,000) Sell Sep 18, 2024 |
Richardson Garrie | (3,070) Sell Sep 16, 2024 |
Mathew Aby EVP & Chief Scientific Officer | (343) Sell Sep 16, 2024 |
Foster Karen Chief Quality Officer | (267) Sell Sep 16, 2024 |